Table of Contents
Epidemiology | Sites | Pathophysiology / etiology | Clinical features | Diagnosis | Laboratory | Radiology images | Prognostic factors | Case reports | Treatment | Clinical images | Gross description | Gross images | Microscopic (histologic) description | Microscopic (histologic) images | Positive stains | Negative stains | Differential diagnosis | Additional referencesCite this page: Rane S. Liposarcoma. PathologyOutlines.com website. https://www.pathologyoutlines.com/topic/testisliposarcoma.html. Accessed December 22nd, 2024.
Epidemiology
- Rare; mean 63 years, range 41 to 87 years but younger patients have been reported
- Most common malignant tumor involving the spermatic cord (46%) (Urol Oncol 2014;32:52)
- Paratesticular liposarcomas account for ~12% of all liposarcomas
- Well differentiated tumors tend to recur, often late yet have a good outcome; dedifferentiated tumors have metastatic potential
Sites
- Usually arise from spermatic cord; also testicular tunica; rarely epididymis
Pathophysiology / etiology
- Recurrent molecular abnormalities have been detected in liposarcomas, which differ between each subtype
- Well differentiated liposarcoma is characterized by the presence of amplification involving 12q13-q15, which can be identified using FISH or CGH
- This amplification is associated with the occurrence of supernumerary ring chromosomes or giant rod chromosomes
- The 12q13-q15 region contains multiple genes implicated in the pathogenesis of liposarcoma, including MDM2, CDK4, HMGA2, TSPAN31, OS1, OS9, CHOP, STAT6 and GLI (Virchows Arch 2010;456:277, Genes Chromosomes Cancer 1999;24:30, Genes Chromosomes Cancer 1995;14:8, Cancer Genet Cytogenet 1997;99:14, Mod Pathol 2014;27:1231)
- Myxoid liposarcoma is characterized by the presence of t(12;16)(q13;p11), which results in the FUS-CHOP gene fusion that is present in over 95% of cases
- Most often, the amino terminal domain of FUS (also known as TLS) is fused to C/EBP homologous protein (CHOP, also known as DDIT3 or GADD153)
- In rare cases, an alternative translocation event is found, t(12;22)(q13;q12), that results in formation of the novel fusion oncogene where EWS takes the place of FUS
- RET, IGF1R and IGF2 are highly expressed in MLPS and promote cell survival through both the PI3K/Akt and Ras-Raf-ERK/MAPK pathways (Hum Pathol 2009;40:1244, Nat Clin Pract Oncol 2007;4:591) and represent potential therapeutic targets
- Pleomorphic liposarcoma shows complex chromosomal abnormalities with gains in 1p, 1q21-q32,2q, 3p, 3q, 5p12-p15, 5q, 6p21, 7p, 7q22 and losses involving 1q, 2q, 3p, 4q, 10q, 11q, 12p13, 13q14, 13q21-qter, 13q23-24
- 60% of pleomorphic liposarcoma show deletion of 13q14.2-q14.3, which houses the RB1 gene
- MAD2 gene is also commonly amplified in pleomorphic liposarcoma (Cancer Res 2007;67:6626, Curr Biol 2010;20:328)
Clinical features
- Painless scrotal mass of longstanding duration is the most common presentation
- Rarely is of recent duration
- May present as an inguinal hernia, hydrocele, hematocoele or other testicular tumor
Diagnosis
- Diagnosis requires histological examination
- Clinical differentiation from other testicular and paratesticular sarcomas is not possible
Laboratory
- No specific laboratory abnormality is known
- Serum markers for germ cell tumors and sex cord tumors are negative
Radiology images
Prognostic factors
- Recurrence of well differentiated paratesticular liposarcoma after complete resection is extremely rare (Malays J Med Sci 2013;20:95)
- Recurrence rate is < 10% when resection margin is 10 mm or greater
- Risk factors for local recurrence / progression:
- High grade tumor morphology
- Large tumor size ( > 5 cm)
- Inadequate / suboptimal resection
Case reports
- 23 year old man with paratesticular myxoid liposarcoma (Rare Tumors 2010;2:e23)
- 46 year old man with paratesticular myxoid / round cell liposarcoma (Pathol Res Pract 2013;209:124)
- 50 year old man with recurrence of paratesticular liposarcoma (World J Surg Oncol 2014;12:276)
- 50 year old man with paratesticular liposarcoma masquerading as a testicular tumor (J Clin Diagn Res 2014;8:165)
- 65 year old man with bilateral paratesticular liposarcoma (J Surg Tech Case Rep 2014;6:15)
- 77 year old man with paratesticular dedifferentiated liposarcoma with leiomyosarcomatous differentiation (Diagn Pathol 2013;8:142)
- Mixed paratesticular liposarcoma with osteosarcoma elements (Clin Transl Oncol 2010;12:148)
- Well differentiated inflammatory liposarcoma (Am J Surg Pathol 1997;21:518)
- Dedifferentiated liposarcoma (Am J Surg Pathol 1994;18:1213)
Treatment
- Usual treatment is orchidectomy through inguinal approach, with adequate margins
- Elective inguinal node dissection is not indicated
- Cases with a margin < 10 mm or with residual tumor may benefit from radiotherapy; liposarcoma is radiosensitive and the well differentiated subtype is most sensitive
- Radiotherapy also useful for unresectable cases
- Role of chemotherapy (ex: doxorubicin) is debated; no clear benefit has been shown
- Surgical excision is also the cornerstone of management of recurrent cases
Clinical images
Gross description
- Tumors are usually large, appear to be relatively circumscribed
- Cut surface may be yellow, fatty with interspersed fibrous septae or may be uniformly firm and white
- Areas of necrosis and hemorrhage may be seen in high grade tumors
Gross images
Microscopic (histologic) description
- Mature adipocytes, atypical spindle cells and multivacuolated lipoblasts embedded in a loose myxoid to dense fibrous stroma
- All variants of liposarcoma may be seen; well differentiated or dedifferentiated liposarcomas are most common
- Heterologous leiomyosarcomatous or osteosarcomatous differentiation (Am J Surg Pathol 2002;26:742) and osseous metaplasia (Case Rep Urol 2015;2015:965876) have been reported but their presence does not appear to affect prognosis
- Pleomorphic liposarcoma accounts for < 5% of cases and is characterized by MFH-like histology with a disorderly pattern, pleomorphic cells, multinucleated bizarre giant cells and lipoblasts
- Giant lipoblasts have enlarged globular or angular hyperchromatic nuclei
- Other variants have also been reported
Microscopic (histologic) images
Images hosted on other servers:
Well differentiated liposarcoma:
Well differentiated with dedifferentiated component:
Dedifferentiated with leiomyosarcomatous component:
Myxoid liposarcoma:
Positive stains
Differential diagnosis
- Aggressive angiomyxoma
- Angiomyolipoma: HMB45 positive
- Embryonal rhabdomyosarcoma
- Fibromatosis: resembles sclerosing liposarcoma but is more cellular, has no atypia, has denser collagen and is CD34 negative
- Inflammatory fibrous pseudotumor: resembles inflammatory liposarcoma but has bland spindle cells
- Inflammatory myofibroblastic tumor
- Lipoma: mimics well differentiated liposarcoma but has no atypical adipocytes and no lipoblasts
- Lymphoma: mimics inflammatory liposarcoma but has monoclonal lymphocytes (usually B cell not T cell)
- Primary retroperitoneal sarcoma extension
- Sclerosing lipogranuloma
Additional references